An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
Clinical trial NCT05056402 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05056402
- Sponsor
- Xiamen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-19
- Primary completion
- 2025-12-31
- Enrollment
- 1382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.